VOYA Investment Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $251K | Buy |
|
|||||
|
2025
Q1 | $109K | Sell |
|
|||||
|
2024
Q4 | $121K | Sell |
|
|||||
|
2024
Q3 | $92.9K | Sell |
|
|||||
|
2024
Q2 | $73.1K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $107K | Buy |
|
|||||
|
2022
Q1 | $90K | Buy |
|
|||||
|
2021
Q4 | $283K | Buy |
|
|||||
|
2021
Q3 | $332K | Buy |
|
|||||
|
2021
Q2 | $403K | Sell |
|
|||||
|
2021
Q1 | $370K | Buy |
|
|||||
|
2020
Q4 | $273K | Buy |
|
|||||
|
2020
Q3 | $213K | Buy |
|
|||||
|
2020
Q2 | $616K | Sell |
|
|||||
|
2020
Q1 | $444K | Buy |
|
|||||
|
2019
Q4 | $359K | Buy |
|
|||||
|
2019
Q3 | $169K | Hold |
|
|||||
|
2019
Q2 | $209K | Buy |
|
|||||
|
2019
Q1 | $290K | Sell |
|
|||||
|
2018
Q4 | $207K | Buy |
|
|||||
|
2018
Q3 | $186K | Hold |
|
|||||
|
2018
Q2 | $210K | Buy |
|
|||||
|
2018
Q1 | $194K | Hold |
|
|||||
|
2017
Q4 | $302K | Hold |
|
|||||
|
2017
Q3 | $399K | Buy |
|
|||||
|
2017
Q2 | $265K | Buy |
|
|||||
|
2017
Q1 | $152K | Hold |
|
|||||
|
2016
Q4 | $172K | Hold |
|
|||||
|
2016
Q3 | $150 | Hold |
|
|||||
|
2016
Q2 | $124K | Buy |
|
|||||
|
2016
Q1 | $114K | Hold |
|
|||||
|
2015
Q4 | $164K | Hold |
|
|||||
|
2015
Q3 | $123K | Hold |
|
|||||
|
2015
Q2 | $131K | Buy |
|